The term sarcoma refers to a broad group of malignant neoplasms (cancers) that originate in the mesenchymal or connective tissues of the body. Unlike carcinomas, which develop in epithelial linings (like skin or internal organs), sarcomas arise in the structural tissues: bones, cartilage, muscles, tendons, fat, blood vessels, and nerves. They are typically highly aggressive and often metastasize through the bloodstream (hematogenous spread) rather than the lymphatic system. Sarcomas are generally divided into two main categories: soft tissue sarcomas (e.g., liposarcoma, leiomyosarcoma) and primary bone sarcomas (e.g., osteosarcoma, Ewing sarcoma).
The literal translation is a “fleshy tumor.” Historically, the term was coined by early anatomists and pathologists because the cut surface of these tumors often resembled the texture and appearance of raw fish or animal flesh, distinct from the harder, more fibrous nature of many carcinomas.
🔀 ALIASES / ALTERNATE TERMS
Soft tissue sarcoma (STS)
Bone cancer / Primary bone tumor
Malignant mesenchymal tumor
Osteosarcoma(specific to bone)
Liposarcoma(specific to fat tissue)
Leiomyosarcoma(specific to smooth muscle)
Angiosarcoma(specific to blood vessels)
🔗 RELATED TERMS
Carcinoma — a cancer arising from epithelial tissue, which is the most common type of cancer (distinguishing it from the rarer sarcoma).
Mesenchyme — the embryonic connective tissue from which all sarcomas ultimately derive.
Metastasis — the spread of cancer cells; sarcomas most frequently metastasize to the lungs via the bloodstream.
Radical resection — an aggressive surgical procedure aimed at removing the tumor along with a wide margin of normal surrounding tissue to prevent recurrence.
Oncology — the medical specialty dedicated to cancer diagnosis and treatment.
Kaposi’s sarcoma — a specific vascular sarcoma caused by Human Herpesvirus 8 (HHV-8), most commonly seen in immunocompromised patients (e.g., HIV/AIDS).
CODING CORNER
🏥 ICD-10-CM CODES
Soft Tissue Sarcomas (Category C49)
Code
Description
C49.11
Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder
C49.12
Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder
C49.21
Malignant neoplasm of connective and soft tissue of right lower limb, including hip
C49.22
Malignant neoplasm of connective and soft tissue of left lower limb, including hip
C49.3
Malignant neoplasm of connective and soft tissue of thorax
C49.9
Malignant neoplasm of connective and soft tissue, unspecified
Bone and Articular Cartilage Sarcomas (Category C40-C41)
Code
Description
C40.21
Malignant neoplasm of long bones of right lower limb
C40.22
Malignant neoplasm of long bones of left lower limb
C41.2
Malignant neoplasm of vertebral column
C41.9
Malignant neoplasm of bone and articular cartilage, unspecified
Specific & Other Sarcomas
Code
Description
C46.0
Kaposi’s sarcoma of skin
C22.3
Angiosarcoma of liver
Z85.831
Personal history of malignant neoplasm of soft tissue
Z85.830
Personal history of malignant neoplasm of bone
🔧 COMMON CPT CODES (Sarcoma-Related Procedures)
CPT Code
Description
20206
Biopsy, muscle, percutaneous needle
20240
Biopsy, bone, open; superficial
21931
Excision, tumor, soft tissue of back or flank, subcutaneous; 3 cm or greater
27615
Radical resection of tumor (e.g., sarcoma), soft tissue of leg or ankle area; less than 5 cm
27365
Radical resection of tumor, bone, femur or knee
88309
Level VI - Surgical pathology, gross and microscopic examination (Extensive resections for soft tissue or bone sarcomas require high-level pathology)
⚠️ Coding Note: Coding for sarcomas in ICD-10-CM requires navigating the Neoplasm Table under “Connective tissue” or “Bone,” rather than the specific organ it may be attached to. You must determine the exact anatomic site and laterality (right vs. left) for extremities. For CPT coding, surgical excisions of sarcomas are complex. You must distinguish between a simple excision and a radical resection (which involves removing the tumor along with a significant margin of surrounding normal tissue/compartment). Pay close attention to the depth (subcutaneous vs. subfascial/intramuscular) and the size of the tumor documented in the operative report.